Analystreport

Crescent Biopharma (NASDAQ:CBIO) had its "sell (e-)" rating reaffirmed by analysts at Weiss Ratings.

Crescent Biopharma, Inc.  (CBIO) 
Last crescent biopharma, inc. earnings: 11/7 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: catalystbiosciences.com/investors